PatientsVille.com Logo

FEAR and Phentermine

PatientsVille

FEAR Symptoms and Causes

A phobia is a type of anxiety disorder. It is a strong, irrational Fear of something that poses little or no real danger.

There are many specific phobias. Acrophobia is a Fear of heights. Agoraphobia is a Fear of public places, and claustrophobia is a Fear of closed-in places. If you become anxious and extremely self-conscious in everyday social situations, you could have a social phobia. Other common phobias involve tunnels, highway driving, water, flying, animals and blood.

People with phobias try to avoid what they are afraid of. If they cannot, they may experience

  • Panic and Fear
  • Rapid heartbeat
  • Shortness of breath
  • Trembling
  • A strong desire to get away

Phobias usually start in children or teens, and continue into adulthood. The causes of specific phobias are not known, but they sometimes run in families.

Treatment helps most people with phobias. Options include medicines, therapy or both.

NIH: National Institute of Mental Health

Check out the latest treatments for FEAR

FEAR treatment research studies

Phentermine clinical trials, surveys and public health registries


Find Drug Side Effect reports



Phentermine Side Effects

Pain (28)
Dyspnoea (27)
Anxiety (26)
Chest Pain (22)
Deep Vein Thrombosis (20)
Nausea (19)
Abdominal Pain (18)
Headache (16)
Blood Pressure Increased (16)
Abdominal Pain Upper (16)
Mitral Valve Incompetence (15)
Cholelithiasis (15)
Cholecystitis Chronic (14)
Pulmonary Embolism (14)
Injury (13)
Vomiting (13)
Ventricular Fibrillation (13)
Myocardial Infarction (13)
Loss Of Consciousness (12)
Dizziness (12)
Colitis Ischaemic (11)
Cardiac Arrest (11)
Gallbladder Disorder (10)
Fatigue (10)
Insomnia (10)
Cerebrovascular Accident (9)
Hypertension (9)
Arteriospasm Coronary (9)
Palpitations (8)
Confusional State (8)
Chest Discomfort (7)
Convulsion (7)
Hypotension (7)
Emotional Distress (7)
Feeling Abnormal (7)
Asthenia (6)
Abnormal Behaviour (6)
Diarrhoea (6)
Pain In Extremity (6)
Hypoaesthesia (6)
Tricuspid Valve Incompetence (6)
Hypercoagulation (5)
Alanine Aminotransferase Increased (5)
Mental Disorder (5)
Heart Rate Increased (5)
Pneumomediastinum (5)
Ventricular Tachycardia (5)
Respiratory Arrest (5)
Pyrexia (5)
Migraine (5)

➢ More


Common Meds

Abilify (10132)
Adderall (1304)
Amlodipine (6664)
Amoxicillin (4387)
Benadryl (1568)
Celebrex (12876 )
Celexa (1342)
Cialis (2975)
Cipro (8580)
Citalopram (7792)
Crestor (18839)
Cymbalta (14373)
Doxycycline (1757)
Effexor (7289)
Flexeril (435)
Flomax (2177)
Fluoxetine (4261)
Gabapentin (4593)
Hydrocodone (2469)
Ibuprofen (8222)
Lantus (10968)
Lexapro (3499)
Lipitor (17769)
Lisinopril (8919)
Lyrica (27148)
Medrol (650)
Mirena (41254)
Mobic (957)
Morphine (5356)
Naproxen (538)
Neurontin (6501)
Oxycodone (4438)
Pradaxa (13372)
Prednisone (5926)
Prilosec (2631)
Prozac (1954)
Seroquel (27216)
Simvastatin (8348)
Synthroid (4452)
Tamiflu (5585)
Topamax (3748)
Tramadol (5054)
Trazodone (1458)
Viagra (5394)
Vicodin (1153)
Wellbutrin (6324)
Xanax (2847)
Zocor (5718)
Zoloft(6792)
Zyrtec(1669)

Recent Reviews

Am linzi from west yorkshire aged 42 av been on them 5 years reason was depression and anxiety attacks. they did give me confidence and took away panic attacks and made me calmer.i travelled long distance in my car without the fear and pani

Am on Dolcet, 3x a day for three weeks already due to herpes zoster pain. For fear of overdosage i stopped taking this, i shifted to Lyrica 75 mg. But the pain continues. Is it okay if I take Lyrica in the morning and dolcet in the afternoon?

Am using melalite 15 from last 2 months... i had an average colour only, but not black. aftr using melalite i have big change in my skin colour. thts why am continuing it. now am fear about stopping it. am big confused that if i stop it who its will

Fear, swetting,anxiety, serious weight loss, addiction. After having drug removed abruptly ( by doctors mistake )side effects lasted for years after, such as: constantly living in the past, thinking backwards, forced thoughts, head ache, lo

First I too cipralex in the month of feb-11 for a period of two months. after again started in July due to fear for a period of one month. then again start in november for one month. now since last two weeks i am trying but the side effects are getti

I am going in next week, and scared to death to take the moviprep for fear of breathing difficulties, does this happen? thanks so much

I can't sleep if i take a percocet, if i do fall asleep i wake up every ten minutes or so in fear, turns my eyes red? (maybe, could be coincidental)

I had a aneurysm 3 years ago under went surgey with coils.I always have this fear i am going to have another one.Since this operation i have developed fluid tention in my legs put on weight seem to have fatty liver(NASH)I still have short memory lose

I have a back problem and I needed physical therapy however I had an immedate problem with Geodon and that problem was severe headaches. I think if your concerned about fear muscle relaxants are a much better choice than Geodon.

I have taken endep 25 for about a year now for insomnia. It has helped a lot and I don't want to come off it, because I fear the anxiety that comes from having no sleep. I do experience dull moods though and I am not as vibrant si

FEAR Clinical Trials and Studies

Treatments might be new drugs or new combinations of drugs, new surgical procedures or devices, or new ways to use existing treatments. The goal of clinical trials is to determine if a new test or treatment works and is safe. Clinical trials can also look at other aspects of care, such as improving the quality of life for people with chronic illnesses. People participate in clinical trials for a variety of reasons. Healthy volunteers say they participate to help others and to contribute to moving science forward. Participants with an illness or disease also participate to help others, but also to possibly receive the newest treatment and to have the additional care and attention from the clinical trial staff.
Rank Status Study
1 Recruiting Targeting Reconsolidation to Prevent Return of FEAR
Condition: FEAR of Flying
Intervention: Behavioral: Virtual Reality Exposure Therapy
Outcome Measures: FEAR of Flying Inventory;   The Questionnaire on Attitudes Toward Flying;   The Beck Depression Inventory;   State Trait Anxiety Inventory- State;   State Trait Anxiety Inventory- Trait
2 Unknown  End-of-Life FEAR in Patients With End-Stage Lung Disease (COPD)
Conditions: Chronic Obstructive Pulmonary Disease;   End-of-Life FEAR;   FEAR About Death and Dying;   Depression
Intervention: Behavioral: A brief psycho-educational intervention
Outcome Measures: Self-reported semi-structured interview about the FEAR of death and dying, needs and wishes at the end-of-life in patients with severe COPD;   St. George's Respiratory Questionnaire (SGRQ);   Short Form Health Survey (Fragebogen zum allgemeinen Gesundheitszustand, SF-36);   Euroqol (EQ);   Patient Health Questionnaire (PHQ);   Hospital Anxiety and Depression Scale (HADS);   Borg Scale;   Diffusion capacity (DLCO);   Blood gas analysis (BGA);   Bodyplethysmographs;   Bio-Impedance-Analysis (BIA);   6-Minute Walk Distance (6 MWD);   Body Mass Index (BMI);   Blood tests;   Multidimensional assessment of attitudes toward death and dying (Fragebogeninventar zur mehrdimensionalen Erfassung des Erlebens gegenüber Sterben und Tod, FIMEST);   COPD- Anxiety -Questionnaire (COPD-Angst-Fragebogen, CAF);   COPD- Disability- Index (CDI);   Differences in COPD admission rates, functional impairment, quality of life and end-of-life FEAR after treatment
3 Unknown  Induction of Women With FEAR of Labor
Condition: FEAR
Intervention: Other: WEDQ-B (questionnaire)
Outcome Measures: experience of delivery;   Operative delivery
4 Recruiting The Effects of Music on FEAR of Childbirth and Outcome of Delivery
Condition: FEAR of Childbirth
Intervention: Behavioral: Music
Outcome Measures: spontaneous vaginal delivery;   Delivery satisfaction
5 Unknown  Art Therapy as Treatment for FEAR of Childbirth
Condition: FEAR of Childbirth
Interventions: Other: Art Therapy and therapeutic conversations;   Other: Therapeutic conversations
Outcome Measure: Scores for the Wijma Delivery Expectancy Questionnaire (W-DEQ)
6 Unknown  Exploring Learning and Unlearning of FEAR
Condition: Healthy Individuals
Interventions: Drug: d-Cycloserine;   Drug: Lactose pill;   Genetic: Saliva sample;   Other: Functional neuroimaging (fMRI)
Outcome Measure: change in BOLD-signal during a FEAR conditioning task
7 Recruiting Cannabinoid Augmentation of FEAR Response in Humans
Condition: FEAR Conditioning
Interventions: Drug: Delta-9-THC;   Drug: PF-04457845;   Drug: Placebo
Outcome Measures: Startle Probe;   Galvanic skin response
8 Unknown  Association of FEAR of Falling and Physical Activity in Rheumatoid Arthritis Comparison Before and After Biological Therapy
Condition: Rheumatoid Arthritis
Intervention:
Outcome Measures: To identify the prevalence and severity of the FEAR of falling in a rheumatoid population;   To explore the effect the treatment with biological agents has on FEAR of falling and physical activity in a rheumatoid population
9 Recruiting Brain Changes in FEAR
Condition: Anxiety Disorders
Intervention:
Outcome Measure:
10 Not yet recruiting Does Transcutaneous Vagal Nerve Stimulation Improves FEAR Extinction in Humans
Condition: Healthy Adults
Interventions: Device: t-VNS;   Device: sham stimulation
Outcome Measure: FEAR response
11 Recruiting Overgeneralization of Conditioned FEAR as a Pathogenic Marker of Anorexia Nervosa
Conditions: Anorexia;   Generalized Anxiety
Intervention:
Outcome Measure: The primary outcome variable is startle response (eye blink).
12 Unknown  Graded Exposure (GEXP) in Vivo Versus Physiotherapy in Complex Regional Pain Syndrome Type I (CRPS-I)
Condition: Complex Regional Pain Syndrome Type I
Interventions: Behavioral: Graded exposure in vivo;   Behavioral: Physiotherapy
Outcome Measures: Functional disability measured with: Radboud Skills Questionnaire (RASQ; Oerlemans, Cup et al., 2000), for upper limbs; Walking Ability Questionnaire (WAQ; Perez et al., 2002), for lower limbs;   Physical activity in daily life;   Body function and structure;   FEAR of movement;   FEAR of pain;   Catastrophizing Scale;   Coping with pain;   Emotional distress;   Participation;   Emotional involvement
13 Unknown  FEAR of Childbirth (Tokophobia) - Etiology, Essence and Clinical Implications
Condition: Phobias
Interventions: Behavioral: Psychological Treatment;   Behavioral: Group Therapy
Outcome Measures: Tokophobia existing and new measures (e.g. Pregnancy anxiety scale, Levin, 1991; Tokophobia subjective scale);   For pregnant subjects - labor preference, duration and pain medication assessment.
14 Recruiting Attention and Interpretation Modification (AIM) for FEAR of Breast Cancer Recurrence: An Intervention Development Study
Condition: Breast Cancer
Intervention: Behavioral: AIM materials and assessments
Outcome Measures: develop and refine materials;   estimate the feasibility and acceptability;   preliminary efficacy
15 Unknown  Exposure-based Treatment for Avoidant Back Pain Patients
Condition: Low Back Pain
Interventions: Behavioral: Exposure in vivo;   Behavioral: Cognitive Behavioural Psychotherapy
Outcome Measures: Change from baseline in pain severity at 3 and 6 months after admission;   Change from baseline in pain disability at 3 and 6 months after admission;   Change in FEAR avoidance from Pretest to two in-between time points to Posttest;   Change in pain catastrophizing from Pretest to two in-between timepoints to Posttest to Follow-up;   Change in emotional distress from Pretest to two in-between timepoints to Posttest to Follow-up;   Change in quality of life from Pretest to two in-between timepoints to Posttest to Follow-up;   Change in physical activity from Pretest to two in-between timepoints to Posttest to Follow-up Time
16 Not yet recruiting Cannabinoid Control of FEAR Extinction Neural Circuits in Post-traumatic Stress Disorder
Condition: Post-Traumatic Stress Disorder
Interventions: Drug: Dronabinol;   Drug: Placebo
Outcome Measures: Brain Measures;   Psychophysiology;   Expectancy Ratings;   Subjective Units of Distress (SUDS);   Mood & Drug Effect Questionnaires;   Physiological
17 Recruiting Effects of Hydrocortisone and D-Cycloserine on FEAR Extinction in Veterans With Posttraumatic Stress Disorder
Condition: Stress Disorders, Posttraumatic
Interventions: Drug: Hydrocortisone;   Drug: D-Cycloserine;   Drug: Placebo
Outcome Measures: Skin Conductance;   Heart Rate;   Eye Blink
18 Recruiting Anti-phobic and Safety Behaviors in the Treatment of Acrophobia
Condition: FEAR of Heights (Acrophobia)
Interventions: Behavioral: Therapist-guided standard exposure therapy;   Behavioral: Exposure therapy with safety behavior fading augmentation;   Behavioral: Exposure therapy with safety behavior fading and anti-phobic action
Outcome Measures: Peak subjective FEAR (0 - 100) upon exposure to heights in the generalization context.;   Acrophobia Questionnaire - Modified (Cohen, 1977; Wolitzky & Telch, 2009);   Height estimation task;   Heart rate;   Galvanic Skin Response;   Treatment Process Questionnaire
19 Unknown  Mechanisms of Panic Disorders Treatment
Conditions: Panic Disorder;   Agoraphobia;   Panic Attacks
Intervention: Behavioral: Cognitive Behavioural Therapy (CBT)
Outcome Measures: Hamilton Anxiety Rating Scale (HARS);   Clinician Global Impression Scale (CGI);   Panic and Agoraphobia Scale (PAS);   Mobility Inventory;   Number of panic attacks
20 Recruiting Cerebral GABA and FEAR Conditioning in PTSD
Condition: Stress Disorders, Post-Traumatic
Intervention:
Outcome Measure: Regional brain gamma-aminobutyric acid (GABA) levels in the ventromedial prefrontal cortex (VMPFC), right anterior insula, and right posterior temporal cortex